← European Medicine Shortage Tracker · all medicines

Indometacin shortage — availability across Europe

Indometacin currently has availability issues reported in 1 European register: Germany.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Shortage  ATC M01AB01 · also listed as: Indometacin · data refreshed 7 August 2026

Key facts

As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Indometacin, covering 1 affected product presentation. The longest-running open report was filed in Germany on 2025-12-31 and has now been open for about 8 months. Where agencies state a cause, unexpectedly high demand lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2026-08-26; the earliest is 2026-08-26. Registers in Germany indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Indometacin is coded M01AB01 — a medicine acting on the musculo-skeletal system — so clinically related products appear under “Related medicines” below.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇩🇪 GermanyShortage
Indometacin AL 50
2025-12-312026-08-26Erhöhte Nachfrage
Alternatives: N/A
register ↗

Full report history (1 register entry)

Every individual register entry for Indometacin in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇩🇪 DEIndometacin AL 50Shortage2025-12-312026-08-26Erhöhte Nachfrage

Frequently asked

Is Indometacin currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: Germany. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Indometacin shortage expected to end?

Agency prognoses on file range from 2026-08-26 to 2026-08-26. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Indometacin?

1 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Indometacin availability data come from?

Directly from the official medicines-agency register that lists Indometacin: BfArM (Germany). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Related medicines (same ATC class)

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Indometacin — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/indometacin/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Indometacin availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/indometacin/">Indometacin shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Indometacin: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.